EXTON, Pa. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Tuesday reported a loss of $11.6 million in its third quarter.
On a per-share basis, the Exton, Pennsylvania-based company said it had a loss of 43 cents. Losses, adjusted for gains related to mergers and acquisitions, were 46 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.
The drugmaker posted revenue of $145,000 in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $2.1 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDRA at https://www.zacks.com/ap/IDRA